ROP:SWX
Roche Holding AG Genussscheine
CHF 345.10
arrow_downward
-1.15%(-4.00) 1D
Oct 1, 9:38:01 AM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROP...
Open
CHF 345.00
High
CHF 346.70
Low
CHF 344.30
Mkt. cap
280.37B
Avg. vol.
960.62K
Volume
74.58K
Dividend
2.84%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
22.49
52-wk high
CHF 375.80
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
Open
CHF 345.00
High
CHF 346.70
Low
CHF 344.30
Mkt. cap
280.37B
Avg. vol.
960.62K
Volume
74.58K
Dividend
2.84%
Quarterly dividend
CHF 2.45
Ex-dividend date
Mar 27, 2025
P/E ratio
22.49
52-wk high
CHF 375.80
52-wk low
CHF 291.00
EPS
CHF 15.33
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
Stock Titan
·
1 hour ago
Roche's eye drug showed vision gains or stable sight in three retinal diseases
Stock Titan
·
2 hours ago
A breast cancer treatment in testing lowered risk of worsening or death by 62% for patients with a tumor mutation.
AD HOC NEWS
·
15 hours ago
Roche Holding stock: FDA accepts fenebrutinib application for priority review
Reuters
·
2 days ago
Roche outlines plans to move towards autonomous AI labs
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com